Intec Pharma Ltd Statistics Share Statistics Intec Pharma Ltd has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 156.6K, so 0% of the outstanding
shares have been sold short.
Short Interest 156.6K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.97 and the forward
PE ratio is null.
Intec Pharma Ltd's PEG ratio is
0.01.
PE Ratio -0.97 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.94 P/FCF Ratio -1.18 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Intec Pharma Ltd.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.81,
with a Debt / Equity ratio of 0.06.
Current Ratio 2.81 Quick Ratio 2.81 Debt / Equity 0.06 Debt / EBITDA -0.07 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-392.44K Employee Count 36 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 124K Effective Tax Rate -0.89%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.14, so Intec Pharma Ltd's
price volatility has been higher than the market average.
Beta 1.14 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 1,050,876
Income Statement
Revenue n/a Gross Profit n/a Operating Income -13.83M Net Income -14.13M EBITDA -12.8M EBIT n/a Earnings Per Share (EPS) -14.3
Full Income Statement Balance Sheet The company has 14.67M in cash and 934K in
debt, giving a net cash position of 13.74M.
Cash & Cash Equivalents 14.67M Total Debt 934K Net Cash 13.74M Retained Earnings -203.55M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.51M
and capital expenditures -22K, giving a free cash flow of -11.53M.
Operating Cash Flow -11.51M Capital Expenditures -22K Free Cash Flow -11.53M FCF Per Share -11.67
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NTEC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NTEC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 27, 2021. It was a
backward
split with a ratio of 1:4.
Last Split Date Jul 27, 2021 Split Type backward Split Ratio 1:4
Scores Altman Z-Score n/a Piotroski F-Score n/a
